Rennes, France

David Drugeon-Hamon

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Interdigital Madison Patent Holdings, Sas. Active years: 2023.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Drugeon-Hamon: Innovator in Audio Technology

Introduction

David Drugeon-Hamon is a notable inventor based in Rennes, France. He has made significant contributions to the field of audio technology, particularly with his innovative approach to controlling sound volume in devices.

Latest Patents

David holds a patent for an "Audio device with learning and adaptive quiet mode capabilities." This invention provides an apparatus and method for controlling the volume of content. In one embodiment, sound associated with content is received along with a request for a volume change. An equalization ratio is obtained based on amplification and compression parameters. The system analyzes whether a volume change will cause a coordinate change in the amplifier or compression levels associated with the content. If a volume change will cause such a change, the volume adjustment is limited, ensuring optimal sound quality.

Career Highlights

David is currently employed at Interdigital Madison Patent Holdings, SAS, where he continues to develop innovative audio solutions. His work has garnered attention for its practical applications in enhancing user experience with audio devices.

Collaborations

David collaborates with talented individuals such as Goulven Querre and Thomas Morin, contributing to a dynamic team focused on advancing audio technology.

Conclusion

David Drugeon-Hamon is a pioneering inventor whose work in audio technology exemplifies innovation and practicality. His contributions are shaping the future of sound control in devices, making a lasting impact in the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…